Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1988 4
1989 1
1990 1
1991 5
1992 3
1993 8
1994 13
1995 7
1996 20
1997 29
1998 15
1999 17
2000 31
2001 36
2002 48
2003 62
2004 76
2005 86
2006 134
2007 149
2008 179
2009 246
2010 268
2011 350
2012 426
2013 488
2014 537
2015 565
2016 619
2017 673
2018 710
2019 752
2020 842
2021 932
2022 905
2023 805
2024 378

Text availability

Article attribute

Article type

Publication date

Search Results

8,852 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.
Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, Salem JE, Beckman JA, Moslehi JJ. Hu JR, et al. Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):e55-e64. doi: 10.1161/ATVBAHA.119.313046. Epub 2020 Jan 23. Arterioscler Thromb Vasc Biol. 2020. PMID: 31969015 Free PMC article. Review.
Androgen deprivation therapy is a cornerstone of prostate cancer treatment. ...We find a divergence between observational studies, which show consistent positive associations between androgen deprivation therapy use and cardiovascular dis …
Androgen deprivation therapy is a cornerstone of prostate cancer treatment. ...We find a divergence between observation …
Androgen deprivation therapy and cardiovascular disease.
Melloni C, Roe MT. Melloni C, et al. Urol Oncol. 2020 Feb;38(2):45-52. doi: 10.1016/j.urolonc.2019.02.010. Epub 2019 Mar 14. Urol Oncol. 2020. PMID: 30879969 Review.
With prolonged survival, PCa patients now suffer from the effects of aging and are at increasing risk for the development of cardiovascular (CV) risk factors and CV disease. Androgen deprivation therapy (ADT) is the mainstay treatment of advanced PCa. ...
With prolonged survival, PCa patients now suffer from the effects of aging and are at increasing risk for the development of cardiovascular …
Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer.
Iwamoto H, Izumi K, Makino T, Mizokami A. Iwamoto H, et al. Cancers (Basel). 2022 Apr 1;14(7):1803. doi: 10.3390/cancers14071803. Cancers (Basel). 2022. PMID: 35406575 Free PMC article. Review.
The recommended treatment for high-risk localized or locally advanced prostate cancer is radical prostatectomy plus extended pelvic lymph node dissection or radiation therapy plus long-term androgen deprivation therapy. However, some patients are treated with …
The recommended treatment for high-risk localized or locally advanced prostate cancer is radical prostatectomy plus extended pelvic lymph no …
Cardiovascular Toxicities of Androgen Deprivation Therapy.
Challa AA, Calaway AC, Cullen J, Garcia J, Desai N, Weintraub NL, Deswal A, Kutty S, Vallakati A, Addison D, Baliga R, Campbell CM, Guha A. Challa AA, et al. Curr Treat Options Oncol. 2021 Apr 17;22(6):47. doi: 10.1007/s11864-021-00846-z. Curr Treat Options Oncol. 2021. PMID: 33866442 Free PMC article. Review.
An intriguing inquiry connects androgen deprivation therapy with reduced risk of COVID-19 infection susceptibility and severity. Recognition of the cardiotoxicity of androgen deprivation therapy and aggressive risk factor modification are …
An intriguing inquiry connects androgen deprivation therapy with reduced risk of COVID-19 infection susceptibility and …
Cardiovascular Toxicity of Androgen Deprivation Therapy.
Boland J, Choi W, Lee M, Lin J. Boland J, et al. Curr Cardiol Rep. 2021 Jul 3;23(8):109. doi: 10.1007/s11886-021-01561-9. Curr Cardiol Rep. 2021. PMID: 34216282 Free PMC article. Review.
PURPOSE OF REVIEW: Androgen deprivation therapy (ADT) is the standard of care for the treatment of advanced prostate cancer (PC). ...
PURPOSE OF REVIEW: Androgen deprivation therapy (ADT) is the standard of care for the treatment of advanced prostate ca …
Androgen Deprivation Therapy Combined With Particle Therapy for Prostate Cancer: A Systematic Review.
Petersen SE, Høyer M. Petersen SE, et al. Front Oncol. 2021 Jun 23;11:695647. doi: 10.3389/fonc.2021.695647. eCollection 2021. Front Oncol. 2021. PMID: 34249753 Free PMC article. Review.
PURPOSE: There is high-level evidence for addition of androgen deprivation therapy to photon-based radiotherapy of the prostate in intermediate- and high-risk prostate cancer. ...Clinical studies on prostate cancer and the treatment combination of particle th …
PURPOSE: There is high-level evidence for addition of androgen deprivation therapy to photon-based radiotherapy of the …
Advances with androgen deprivation therapy for prostate cancer.
Yu EM, Aragon-Ching JB. Yu EM, et al. Expert Opin Pharmacother. 2022 Jun;23(9):1015-1033. doi: 10.1080/14656566.2022.2033210. Epub 2022 Feb 2. Expert Opin Pharmacother. 2022. PMID: 35108137 Review.
INTRODUCTION: Androgen deprivation therapy (ADT) has been a treatment of choice for prostate cancer in almost all phases, particularly in the locally advanced, metastatic setting in both hormone-sensitive and castration-resistant diseaseand in those who are u …
INTRODUCTION: Androgen deprivation therapy (ADT) has been a treatment of choice for prostate cancer in almost all phase …
CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY.
Boban M. Boban M. Acta Clin Croat. 2019 Nov;58(Suppl 2):60-63. doi: 10.20471/acc.2019.58.s2.09. Acta Clin Croat. 2019. PMID: 34975199 Free PMC article. Review.
The leading cause of death in patients with prostate cancer are cardiovascular diseases. Androgen deprivation therapy is the mainstay of treatment in prostate cancers. ...
The leading cause of death in patients with prostate cancer are cardiovascular diseases. Androgen deprivation therapy i …
miRNAs and androgen deprivation therapy for prostate cancer.
Konoshenko MY, Bryzgunova OE, Laktionov PP. Konoshenko MY, et al. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188625. doi: 10.1016/j.bbcan.2021.188625. Epub 2021 Sep 15. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34534639 Review.
Androgen deprivation therapy (ADT) is mainly used for the treatment of advanced, metastatic or recurrent prostate cancer (PCa). ...
Androgen deprivation therapy (ADT) is mainly used for the treatment of advanced, metastatic or recurrent prostate cance …
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice.
Kim J, Freeman K, Ayala A, Mullen M, Sun Z, Rhee JW. Kim J, et al. Curr Oncol Rep. 2023 Sep;25(9):965-977. doi: 10.1007/s11912-023-01424-2. Epub 2023 Jun 5. Curr Oncol Rep. 2023. PMID: 37273124 Free PMC article. Review.
PURPOSE OF THE REVIEW: There have been increasing reports of cardiovascular complications of androgen deprivation therapy (ADT) leading to worse outcomes among patients with prostate cancer. ...
PURPOSE OF THE REVIEW: There have been increasing reports of cardiovascular complications of androgen deprivation therapy …
8,852 results